Tag: Tiotropium

Posted on

Boehringer Ingelheim’s tiotropium shows promising results in patients with … – News-Medical.net

Boehringer Ingelheim's tiotropium shows promising results in patients with …
News-Medical.net
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society …
Phase III results: tiotropium* Respimat® effective in symptomatic asthma …EON: Enhanced Online News (press release)
Boehringer Ingelheim reports positive data from symptomatic asthma trialsZenopa

all 3 news articles »

View full post on asthma – Google News

Posted on

Phase III Study: Tiotropium Effective In Symptomatic Asthma Patients – Science 2.0 – Science 2.0

Phase III Study: Tiotropium Effective In Symptomatic Asthma Patients – Science 2.0
Science 2.0
Tiotropium delivered by the Respimat(R) Soft Mist(TM) Inhaler (SMI) increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least inhaled corticosteroids …
Phase III results: tiotropium(*) Respimat(R) effective in symptomatic asthma …Wall Street Journal (press release)
Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a …PR Newswire (press release)

all 4 news articles »

View full post on asthma – Google News

Posted on

Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma … – The Pharma Letter

Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma …
The Pharma Letter
German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III UniTinA-asthma program relating to its already-marketed drug Spiriva (tiotropium) at the 2013 American Academy of Allergy, Asthma & Immunology …
Boehringer Ingelheim drug shows benefits in new asthma trialZenopa

all 2 news articles »

View full post on asthma – Google News

Posted on

New data from Boehringer Ingelheim’s tiotropium Respimat Phase III UniTinA … – News-Medical.net

New data from Boehringer Ingelheim's tiotropium Respimat Phase III UniTinA …
News-Medical.net
These were the main findings from a new subset of data from the Phase III UniTinA-asthma® programme presented for the first time today at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas.
Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic …PR Newswire (press release)

all 2 news articles »

View full post on asthma – Google News

Posted on

Phase III results: tiotropium* Respimat® is effective in symptomatic asthma … – Business Wire (press release)

Phase III results: tiotropium* Respimat® is effective in symptomatic asthma …
Business Wire (press release)
SAN ANTONIO, Texas–(BUSINESS WIRE)–Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite treatment with at least ICS†/LABA‡, irrespective …
Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic …PR Newswire (press release)

all 2 news articles »

View full post on asthma – Google News

Posted on

Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic … – PR Newswire (press release)

Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic …
PR Newswire (press release)
SAN ANTONIO, Feb. 23, 2013 /PRNewswire/ — Boehringer Ingelheim presented today a new subset of data from the Phase III UniTinA-asthma™ program at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San …

and more »

View full post on asthma – Google News

Posted on

Addition of tiotropium effective in poorly controlled asthma – Medical Xpress

Addition of tiotropium effective in poorly controlled asthma
Medical Xpress
For patients with poorly controlled asthma, the addition of tiotropium to standard therapy is beneficial, according to a study published online Sept. 3 in the New England Journal of Medicine to coincide with presentation at the annual meeting of the …
Tiotropium significantly reduces asthma exacerbationsPharmacy Europe

all 3 news articles »

View full post on asthma – Google News

Posted on

New data from Boehringer Ingelheim and Pfizer’s tiotropium clinical studies on … – News-Medical.net

New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on …
News-Medical.net
New data to be presented at the Annual Congress of the European Respiratory Society (ERS 2012), in Vienna, Austria, will shed light on the current and potential future role of tiotropium, the first once-daily long-acting inhaled anticholinergic for …
BOEHRINGER INGELHEIM GMBH : Key results from new tiotropium studies in …4-traders

all 6 news articles »

View full post on asthma – Google News